title: Does zidovudine reduce tumour necrosis factor-alpha in HIV-positive patients?
authors.forename: L
authors.initials: L
authors.lastname: Cremoni
authors.forename: L L
authors.initials: LL
authors.lastname: Vaira
authors.forename: P
authors.initials: P
authors.lastname: D'Amico
authors.forename: M G
authors.initials: MG
authors.lastname: Grassi
authors.forename: F
authors.initials: F
authors.lastname: Milazzo
mesh_terms: D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism* / Q000502:physiology; D014779:Virus Replication / Q000502:physiology; D015215:Zidovudine / Q000494:pharmacology*
chemical_list: D014409:Tumor Necrosis Factor-alpha; D015215:Zidovudine